Bortezomib consolidation post‐ASCT as frontline therapy for multiple myeloma deepens disease response and MRD‐negative rate whilst maintaining QOL and response to re‐treatment at relapse. (20th November 2018)

Record Type:: Journal Article
Title:: Bortezomib consolidation post‐ASCT as frontline therapy for multiple myeloma deepens disease response and MRD‐negative rate whilst maintaining QOL and response to re‐treatment at relapse. (20th November 2018)
Main Title:: Bortezomib consolidation post‐ASCT as frontline therapy for multiple myeloma deepens disease response and MRD‐negative rate whilst maintaining QOL and response to re‐treatment at relapse
Authors:: Cohen, Oliver C.
Counsell, Nicholas
Rabin, Neil
Popat, Rakesh
Owen, Roger G.
Popova, Bilyana
Schofield, Oliver
Clifton‐Hadley, Laura
Lyons‐Lewis, Janet
Rawstron, Andy
Spence, Christopher
de Tute, Ruth M.
Hughes, Derralynn
Moore, Sally
Smith, Paul
Yong, Kwee L.
Abstract:
Is Part Of:: British journal of haematology. Volume 185:Number 5(2019)
Journal:: British journal of haematology
Issue:: Volume 185:Number 5(2019)
Issue Display:: Volume 185, Issue 5 (2019)
Year:: 2019
Volume:: 185
Issue:: 5
Issue Sort Value:: 2019-0185-0005-0000
Page Start:: 948
Page End:: 951
Publication Date:: 2018-11-20
Subjects:: myeloma -- transplantation -- bortezomib -- consolidation -- quality of life
Hematology -- Periodicals
Blood -- Diseases -- Periodicals
616.15
Journal URLs:: http://www.blacksci.co.uk/%7Ecgilib/jnlpage.bin?Journal=bjh&File=bjh&Page=aims ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2141 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/bjh.15649 ↗
Languages:: English
ISSNs:: 0007-1048
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2309.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 10578.xml